Stockreport

Sanofi SA (SNY) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Developments [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF ALTUVIIIO Sales: EUR325 million, up 42%. Beyfortus Sales: EUR284 million. Sarclisa Sales: EUR167 million, up 30%. Ayvakit Sales: EUR170 million. Heplisav-B Sale [Read more]